Fractyl Health (Nasdaq: GUTS) reported that Revita met its six-month co-primary endpoint in the ongoing REMAIN-1 study of post-GLP-1 weight maintenance. The randomized, double-blind, sham-controlled ...
The Fractyl Health, Inc. stock price fell by -62.74% on the last day (Friday, 16th Oct 2026) from $4.16 to $1.55. During the last trading day the stock fluctuated 50.33% from a day low at $1.53 to a ...
Gretel has announced her long-awaited debut album, Squish, due for release on April 10 via Breadcrumb Records / AWAL, and today shares its rollicking title track. Born from gothic fairytales, girlhood ...
Fractyl Health, Inc. is a metabolic therapeutics company. It develops medical device solutions for the treatment of metabolic diseases, which includes type 2 diabetes and obesity. The company was ...
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results